Cargando…

Asia prostate cancer study (A-CaP Study) launch symposium

The Asian Prostate Cancer (A-CaP) Study is an Asia-wide initiative that has been developed over the course of 2 years. The A-CaP Study is scheduled to begin in 2016, when each participating country or region will begin registration of newly diagnosed prostate cancer patients and conduct prognosis in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akaza, Hideyuki, Hirao, Yoshihiko, Kim, Choung-Soo, Oya, Mototsugu, Ozono, Seiichiro, Ye, Dingwei, Cooperberg, Matthew, Hinotsu, Shiro, Lee, Ji Youl, Zhu, Gang, Namiki, Mikio, Horie, Shigeo, Chung, Byung Ha, Chen, Chung-Hsin, Fai, Ng Chi, Hakim, Lukman, Chiong, Edmund, Letran, Jason, Umbas, Rainy, Suzuki, Kazuhiro, Nishimura, Kazuo, Ong, Teng Aik, Lojanapiwat, Bannakij, Wu, Tong-lin, Kim, Wun-Jae, Murphy, Declan, Ogawa, Osamu, Carroll, Peter, Naito, Seiji, Tsukamoto, Taiji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Pacific Prostate Society 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031897/ https://www.ncbi.nlm.nih.gov/pubmed/27689065 http://dx.doi.org/10.1016/j.prnil.2016.03.001

Ejemplares similares

Report of the Second Asian Prostate Cancer (A-CaP) Study Meeting
por: Kim, Choung-Soo, et al.
Publicado: (2017)

Seventh Joint Meeting of K-J-CaP and CaPSURE: extending the global initiative to improve prostate cancer management
por: Akaza, Hideyuki, et al.
Publicado: (2014)

Report of the third Asian Prostate Cancer study meeting
por: Lojanapiwat, Bannakij, et al.
Publicado: (2019)

Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community‐based multi‐institutional database across Japan using propensity score matching
por: Onozawa, Mizuki, et al.
Publicado: (2018)

Evaluation of primary androgen deprivation therapy in prostate cancer patients using the J-CAPRA risk score
por: Akaza, Hideyuki, et al.
Publicado: (2013)

A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancer
por: Akaza, Hideyuki, et al.
Publicado: (2016)

ELIGANT: a Phase 4, interventional, safety study of leuprorelin acetate (ELIGARD(®)) in Asian men with prostate cancer
por: Malek, Rohan, et al.
Publicado: (2022)

The ideal puncture approach for PCNL: Fluoroscopy, ultrasound or endoscopy?
por: Lojanapiwat, Bannakij
Publicado: (2013)

Efficacy and safety of therapies for advanced prostate cancer in Asia: Evidence from a systematic literature review
por: Saad, Marniza, et al.
Publicado: (2022)

Background factors and short-term health-related quality of life in patients who initially underwent radical prostatectomy or androgen deprivation therapy for localized prostate cancer in a Japanese prospective observational study (J-CaP Innovative Study-1)
por: Ueno, Satoru, et al.
Publicado: (2018)

A randomized controlled trial evaluating the effect of low-dose chlormadinone in patients with low-risk prostate cancer: PROSAS study
por: Sugimoto, Mikio, et al.
Publicado: (2021)

Efficacy and safety of a 3-month dosing regimen of degarelix in Japanese patients with prostate cancer: a phase II maintenance-dose-finding study
por: Ozono, Seiichiro, et al.
Publicado: (2017)

The efficacy of peritubal analgesic infiltration in postoperative pain following percutaneous nephrolithotomy – A prospective randomized controlled study
por: Lojanapiwat, Bannakij, et al.
Publicado: (2015)

Managing advanced prostate cancer in the Asia Pacific region: “Real‐world” application of Advanced Prostate Cancer Consensus Conference 2019 statements
por: Chiong, Edmund, et al.
Publicado: (2022)

Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration‐resistant prostate cancer: AFTERCAB study
por: Uemura, Hiroji, et al.
Publicado: (2021)

Correlation and diagnostic performance of the prostate-specific antigen level with the diagnosis, aggressiveness, and bone metastasis of prostate cancer in clinical practice
por: Lojanapiwat, Bannakij, et al.
Publicado: (2014)

Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trial
por: Oyama, Masafumi, et al.
Publicado: (2017)

Efficacy and safety of 3‐month dosing regimen of degarelix in Japanese subjects with prostate cancer: A phase III study
por: Ozono, Seiichiro, et al.
Publicado: (2018)

Guy's Stone Score (GSS) Based on Intravenous Pyelogram (IVP) Findings Predicting Upper Pole Access Percutaneous Nephrolithotomy (PCNL) Outcomes
por: Lojanapiwat, Bannakij, et al.
Publicado: (2016)

Key predictive factors for efficacy of axitinib in first-line metastatic renal cell carcinoma: subgroup analysis in Japanese patients from a randomized, double-blind phase II study
por: Tomita, Yoshihiko, et al.
Publicado: (2016)

Evaluation of efficacy and safety of sorafenib in kidney cancer patients aged 75 years and older: a propensity score-matched analysis
por: Tatsugami, Katsunori, et al.
Publicado: (2018)

Efficacy and safety of sorafenib for advanced renal cell carcinoma: real-world data of patients with renal impairment
por: Tatsugami, Katsunori, et al.
Publicado: (2018)

United in Fight against prOstate cancer (UFO) registry: first results from a large, multi‐centre, prospective, longitudinal cohort study of advanced prostate cancer in Asia
por: Uemura, Hirotsugu, et al.
Publicado: (2020)

The Protective Effect of Lycopene on Prostate Growth Inhibitory Efficacy by Decreasing Insulin Growth Factor-1 in Indonesian Human Prostate Cancer Cells
por: Tjahjodjati,, et al.
Publicado: (2020)

Efficacy and Safety of Axitinib Versus Sorafenib in Metastatic Renal Cell Carcinoma: Subgroup Analysis of Japanese Patients from the Global Randomized Phase 3 AXIS Trial
por: Ueda, Takeshi, et al.
Publicado: (2013)

Outcomes and predictors of localized or locally-advanced prostate cancer treated by radiotherapy in Indonesia
por: Supit, Wempy, et al.
Publicado: (2013)

Anxiety level of early- and late-stage prostate cancer patients
por: Johanes, Charles, et al.
Publicado: (2013)

Prospective performance of the Prostate Health Index in prostate cancer detection in the first prostate biopsy of men with a total prostatic specific antigen of 4–10 ng/mL and negative digital rectal examination
por: Sriplakich, Supon, et al.
Publicado: (2018)

Efficacy and safety of leuprorelin acetate 6-month depot in prostate cancer patients: a Phase III, randomized, open-label, parallel-group, comparative study in Japan
por: Suzuki, Kazuhiro, et al.
Publicado: (2015)

Scoping review: hotspots for COVID-19 urological research: what is being published and from where?
por: Qu, Liang G., et al.
Publicado: (2020)

Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration‐resistant prostate cancer: Real‐world experience in the Southeast Asian cohort
por: Lim, Jasmine, et al.
Publicado: (2020)

The impact of obesity towards prostate diseases
por: Parikesit, Dyandra, et al.
Publicado: (2016)

Prostate specific antigen (PSA) kinetic as a prognostic factor in metastatic prostate cancer receiving androgen deprivation therapy: systematic review and meta-analysis
por: Afriansyah, Andika, et al.
Publicado: (2018)

Launched
Publicado: (1885)

Oral sitafloxacin vs intravenous ceftriaxone followed by oral cefdinir for acute pyelonephritis and complicated urinary tract infection: a randomized controlled trial
por: Lojanapiwat, Bannakij, et al.
Publicado: (2019)

The incidence, mortality, and risk factors of prostate cancer in Asian men
por: Ha Chung, Byung, et al.
Publicado: (2019)

Clinical studies investigating the use of leuprorelin for prostate cancer in Asia
por: Chung, Byung Ha, et al.
Publicado: (2020)

Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study
por: Uemura, Hiroji, et al.
Publicado: (2022)

Thrombus-like Tumor of Renal Cell Carcinoma Mimicking Transitional Cell Carcinoma of Kidney: A Case Report
por: Parikesit, Dyandra, et al.
Publicado: (2016)

Case of perinephric abscess disguising as renal tumor
por: Raharja, Putu Angga Risky, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lap2uo3codvqeskfae36otpchc